ANDRO treatment induced proliferation and increased the density of immature neurons in the dentate gyrus of AD mice, concomitantly with an increase in hippocampal levels of β-catenin and NeuroD1 in the hippocampus (Varela-Nallar et al., 2015). The gene discussed is NEUROD1; the disease is Alzheimer disease.